Zimmer Biomet to buy Monogram for $177M in cash

5 hours ago 1

Zimmer Biomet (NYSE:ZBH) has agreed to acquire all outstanding shares of orthopedic robotics company Monogram Technologies (NASDAQ:MGRM) for an upfront payment of $4.04 per share in cash, corresponding to an equity value of ~$177M and an enterprise value of ~$168M.

Recommended For You

More Trending News

Read Entire Article